The people
Open roles via the TechTO Job Board
Working at Phenomic AI
Browse open roles across the community on the TechTO Job Board — Canada’s most connected tech network. Phenomic AI’s roles show up here whenever they post.
Open roles on the TechTO Job Board ↗Or their own careers page: phenomic.ai/careers ↗Jobs live on jobs.techto.org — the only structured source. We link to it rather than scraping career sites, so the board is always the source of truth.
On the TechTO stage
Every talk is searchable — ask the archive about Phenomic AI ↗
About
Phenomic AI was born in Toronto in 2017 and went through the 2017/18 Creative Destruction Lab cohort at the University of Toronto's Rotman School. It launched publicly in October 2020 with US$6 million in financing and a platform aimed squarely at stroma-rich cancers, an area where conventional screening struggles. In November 2023 it signed a collaboration and licensing agreement with Boehringer Ingelheim to discover targets in stroma-rich cancers.
Backers
CTI Life Sciences Fund, AV8 Ventures, Luminous Ventures, Viva BioInnovator · Creative Destruction Lab 2017/18
Quick answers
What does Phenomic AI do?
It applies machine learning to microscopy and single-cell data to identify drug targets in the tumour stroma, the tissue around solid tumours that limits how well treatments work.
Who founded Phenomic AI?
Oren Kraus and Sam Cooper, in Toronto in 2017. Kraus did his PhD in Brendan Frey's lab at the University of Toronto.
Who is Phenomic AI working with?
Boehringer Ingelheim, under a 2023 collaboration and licensing agreement to discover targets in stroma-rich cancers reported at more than US$500 million including milestones.